CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Belgium

5 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT06858579
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Trial Treatment · Phase 3 · Dianthus Therapeutics
Cinical Study Site, Anderlecht · Cinical Study Site, Brussels
Registry updated 2026-10-28
NCT06290141
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 3 · Sanofi
Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven
Registry updated 2026-10-19
NCT07032662
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2 · Immunovant Sciences GmbH
UZ Leuven, Leuven
Registry updated 2026-09-30
2024-517529-26-00
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Trial Treatment · Phase 3 · Dianthus Therapeutics Inc.
Hopital Erasme, Anderlecht · Centre Hospitalier Regional de la Citadelle, Liège
Registry updated 2026-08-28
NCT06183645
Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
Research · Centre Hospitalier Universitaire de Liege
CHR Citadelle, Liège
Registry updated 2025-02-12

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)